Manage — SMN2 Splicing Enhancer (Oral)
Edit fields and add or remove reviews, snapshots, outcomes, evidence claims, and documents.
Asset fields
Reviews
- Internal · mixed/high · IC review
Snapshots
- Q4 2024
- Q3 2024
- Q2 2024
Outcomes
- Clinical entry · 2024-07-01
Evidence claims
- commercial / Standard of Care
- scientific / Mechanistic Rationale
- translational / Biomarkers
Applications
- R. Halvorsen · funded · USD1,200,000
Funding events
- milestone_payment · USD500,000 · 2024-10-15
- award · USD1,200,000 · 2023-09-01
Documents
Application PDFs, reviewer forms, decks — attached as evidence (max 25 MB).
No documents yet.